ZA200606220B
(en )
2008-04-30
Galenic formulations of organic compounds
IL177566A0
(en )
2006-12-10
Pharmaceutical formulations
ZA200900345B
(en )
2010-05-26
Preparation of pharmaceutical formulations
GB0426301D0
(en )
2004-12-29
Pharmaceutical formulations
EP1631239A4
(en )
2008-03-05
Pharmaceutical compositions comprising active vitamin d compounds
ZA200705363B
(en )
2008-08-27
Pharmaceutical compositions comprising amorphous benzimidazole compounds
ZA200705011B
(en )
2010-01-27
Formulations of substituted benzoxazoles
IL180031A0
(en )
2007-05-15
Stable pharmaceutical formulations of benzimidazole compounds
GB0416397D0
(en )
2004-08-25
Pharmaceutical formulations
GB0423800D0
(en )
2004-12-01
New pharmaceutical formulations
IS7290A
(en )
2005-11-29
Pharmaceutical formulations containing risperidone
GB0406048D0
(en )
2004-04-21
Drug formulations
AU2003238896A1
(en )
2003-12-22
Stabilized pharmaceutical compositions containing benzimidazole compounds
HK1098970A
(en )
2007-08-03
Stable pharmaceutical formulations of benzimidazole compounds
GB2404856B8
(en )
2008-03-13
Stable pharmaceutical composition of rabeprazole
IL172304A0
(en )
2006-04-10
Pharmaceutical compositions comprising active vitamin d compounds
HK1098693A
(en )
2007-07-27
Galenic formulations of organic compounds
HK1110525A
(en )
2008-07-18
Formulations of substituted benzoxazoles
HK1103620A
(en )
2007-12-28
Pharmaceutical formulations
HK1107761A
(en )
2008-04-18
Organo-gel formulations for therapeutic applications
HK1100278A
(en )
2007-09-14
Nanoparticle formulations of platinum compounds
AU2004902190A0
(en )
2004-05-13
Pharmaceutical Formulation
HK1119909A
(en )
2009-03-20
Pharmaceutical formulations
HK1067986A
(en )
2005-04-22
Stable pharmaceutical compositions of desloratadine
GB0417042D0
(en )
2004-09-01
Stable pharmaceutical formulation